76 views
0

WHY THIS MATTERS IN BRIEF

Being able to diagnose cognitive conditions using just a smartphone, even if you have no formal access to healthcare, will help millions of people catch the signs of dementia earlier, meaning they can seek treatment sooner.

 

WinterLight Labs in the US have just announced they’ve developed a “proprietary Artificial Intelligence (AI) based diagnostic platform” that can “objectively assess and monitor cognitive health.”

 

RELATED
The end of all disease by 2115, Zuckerberg shows off the team hoping to cure the world

 

In laymans terms this means we now have a way to detect and diagnose cognitive diseases, such as Alzheimers and Dementia using nothing more than a smartphone app and our voice, and it’s the continuation of a trend I’m seeing that’s helping democratise access to healthcare and give hundreds of millions of people around the world who still have no formal access to primary or secondary healthcare access to powerful smartphone based detection and diagnostic tools that help them detect the onset of general disease, heart conditions, inherited genetic disorders, pancreatic cancers, and skin cancer with nothing more than a smartphone and a free app.

 

 

Winterlight’s platform uses AI to analyse the users natural speech to detect, diagnose and monitor the appearance and onset of cognitive conditions including Aphasia, Alzheimers, dementia and more by analysing short one minute samples of their speech, and the app can also characterise the speaker’s acoustic, cognitive, and linguistic state, including articulation, lexical diversity, semantic content, and syntactic complexity as well.

 

RELATED
Robo journalists covered the US election for the Washington Post

 

Using samples of a person’s speech, WinterLight’s platform analyses hundreds of linguistic cues and can detect Alzheimers, dementia and other conditions with accuracies between 82 percent and 100 percent, as reported in their peer reviewed academic studies.

WinterLight’s platform also provides major improvements over current pencil and paper tests which can be coarse, challenging, costly, subjective, and time consuming to administer, additionally the platform also has applications in clinical trials, long term and primary care, and speech language pathology, and as the number of people with dementia and other cognitive conditions continues to increase this app couldn’t come soon enough to help people identify their onset, and then, hopefully, help them get the care they need.

About author

Matthew Griffin

Matthew Griffin, award winning Futurist and Founder of the 311 Institute is described as "The Adviser behind the Advisers." Recognised for the past five years as one of the world's foremost futurists, innovation and strategy experts Matthew is an author, entrepreneur international speaker who helps investors, multi-nationals, regulators and sovereign governments around the world envision, build and lead the future. Today, asides from being a member of Centrica's prestigious Technology and Innovation Committee and mentoring XPrize teams, Matthew's accomplishments, among others, include playing the lead role in helping the world's largest smartphone manufacturers ideate the next five generations of mobile devices, and what comes beyond, and helping the world's largest high tech semiconductor manufacturers envision the next twenty years of intelligent machines. Matthew's clients include Accenture, Bain & Co, Bank of America, Blackrock, Bloomberg, Booz Allen Hamilton, Boston Consulting Group, Dell EMC, Dentons, Deloitte, Deutsche Bank, Du Pont, E&Y, Fidelity, Goldman Sachs, HPE, Huawei, JP Morgan Chase, KPMG, Lloyds Banking Group, McKinsey & Co, Monsanto, PWC, Qualcomm, Rolls Royce, SAP, Samsung, Schroeder's, Sequoia Capital, Sopra Steria, UBS, the UK's HM Treasury, the USAF and many others.

Your email address will not be published. Required fields are marked *